Navigation Links
DURECT Corporation Announces Third Quarter 2010 Financial Results
Date:11/3/2010

m clinical trials for our drug candidates, our failure to achieve the performance milestones or commercial sales that trigger the referenced payments or royalties under our collaborative agreements, our (and that of our third party collaborators where applicable) difficulty or failure to obtain approvals from regulatory agencies with respect to development activities and products, design, enroll, conduct and complete clinical trials, complete the design, development, and manufacturing process development of the referenced drug candidates, consummate collaborative agreements relating to our drug candidates and technologies, manufacture and commercialize the referenced drug candidates, obtain marketplace acceptance of the referenced drug candidates, avoid infringing patents held by other parties and secure and defend patents of our own, and manage and obtain capital to fund our growth, operations and expenses. Further information regarding these and other risks is included in DURECT's Form 10-Q on August 5, 2010 under the heading "Risk Factors."DURECT CORPORATIONSTATEMENT OF OPERATIONS DATA(in thousands, except per share amounts)(Unaudited)Three months ended Nine months ended September 30, September 30, 2010200920102009Collaborative research and development and other revenue

$
5,689$
3,027$
4,162$
9,545Product revenue, net

2,4275,3518,93310,037Total revenues

8,1168,37823,09519,582Operating expenses:Cost of product revenues (1)

8592,8343,0984,495Research and development (1)

8,1427,59826,76725,534Selling, general and administrative (1)

3,8063,55410,89211,588Total operating expenses

12,80713,98640,75741,617Loss from operations

(4,691)(5,608)(17,662)(22,035)Other income (expense):Interest and other income

4682105367Interest and other expense

(2)(9)(25)(31)Net other income 447380336Net loss$
(4,647)$
(5,535)$
(17,582)$
(21,699)Net loss per share, basic and diluted

$
(0
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call
2. DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference
3. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
4. DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
5. DURECT to Present at the Jefferies Global Life Sciences Conference
6. DURECT to Present at the Rodman & Renshaw Global Healthcare Conference
7. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
8. DURECT to Present at the Barclays Capital Global Healthcare Conference
9. DURECT to Present at the Cowen and Company Healthcare Conference
10. DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results
11. DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly ... and painless for patients to self-inject prescription drugs in the ... including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... grow to $220B by 2018, according to analysts.   Many of ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast ... Conference on Wednesday, November 10, 2010.  The presentation is ... Time).  The session may be accessed through the Company,s ... page.  An archived version of the presentation will be ...
... than half of the life sciences start-up companies in ... of funding through the Therapeutic Discovery Project Credit under ... of 2010. Seed ... SonarMed all learned today from the Internal Revenue Service ...
Cached Medicine Technology:Indiana Life Sciences Start Ups Garner More than $1.5 Million in Competitive Federal Funding 2
(Date:4/24/2014)... Ever since it was first identified more than ... to play an integral role in preventing the onset ... either lost or mutated, malignant cells can grow unchecked ... by investigators at Beth Israel Deaconess Medical Center (BIDMC) ... effects and how its loss or alteration can set ...
(Date:4/24/2014)... with the negative and stressful outcomes for parents who ... a life-limiting illness, says a recent study led by ... the challenges are numerous and life-changing and stress levels ... the Waterloo-led research reported positive outcomes as well, a ... the most recent issue of the American Journal ...
(Date:4/24/2014)... for BrainHealth will bring together national experts to ... at its inaugural Brain Health Summit, titled "The ... will include Dr. Sandra Bond Chapman, founder and ... Senator Chuck Grassley (R-IA), U.S. Representative Chaka Fattah ... Policy and Early Learning, U.S. Department of Education. ...
(Date:4/24/2014)... to the epidemic of prescription opioid overdose deaths was ... Medicine by leaders of agencies in the U.S. ... calls upon health care providers to expand their use ... deaths, and describes a number of misperceptions that have ... also discusses how medications can be used in combination ...
(Date:4/24/2014)... Dartmouth has been awarded one of 30 grants from ... Lead Academic Participating Site in its new National ... a select groups of investigators charged with distributing resources ... The NCTN grant system reflects recommendations from a ... to achieve four goals:, Faster design, launch, ...
Breaking Medicine News(10 mins):Health News:Surprising new insights into the PTEN tumor suppressor gene 2Health News:Surprising new insights into the PTEN tumor suppressor gene 3Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3
... Campaign Explores Decisions Made by the Tobacco Industry, Impact on Americans ... /PRNewswire/ -- Each and every ... heart disease and cancers, to emphysema and strokes. The latest advertising ... the kinds of decisions tobacco industry executives undertake -- decisions that ...
... will present at the Goldman Sachs 30th Annual Global Healthcare ... and chief executive officer, and Thomas C. Freyman, executive vice ... on the company at 9:20 a.m. Central time. , ... accessible through Abbott,s Investor Relations Web site at ...
... ORLANDO - A vaccine for one of the most lethal ... survival for patients when combined with the immunotherapy drug, Interleukin-2, ... Anderson Cancer Center. The findings, presented today at ... vaccine study in the disease - and one of ...
... must take place if a wound is to heal or ... through a branching and further growth of a vessel against ... at Uppsala University and its University Hospital has shown that ... The findings, published today in the journal Nature Medicine ...
... of Abdominal Aortic Aneurysms , , IRVINE, ... ELGX ) today announced the full commercial launch of ... of large neck abdominal aortic aneurysms (AAA). The IntuiTrak ... delivery systems that enhance vascular accessibility and maneuverability while ...
... K9 Clone DOG-1 Immunohistochemical and H. pylori Monoclonal Antibody ... PLUS Diagnostics , a leading U.S. ... services, announced today that it is the first national ... diagnoses the rare gastrointestinal stromal tumor ("GIST"). Known ...
Cached Medicine News:Health News:Video: truth(R) Asks: 'Do You Have What it Takes?' 2Health News:Video: truth(R) Asks: 'Do You Have What it Takes?' 3Health News:Video: truth(R) Asks: 'Do You Have What it Takes?' 4Health News:Vaccine shows therapeutic promise against advanced melanoma 2Health News:Vaccine shows therapeutic promise against advanced melanoma 3Health News:Model for new generation of blood vessels challenged 2Health News:Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 2Health News:Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 3Health News:PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests 2
... SAFE-T-FILL Capillary Blood Collection Tubes are 100% ... a wide range of applications, the Capillary ... tube, attached cap and a micro tube.,The ... the blood into the micro tube thereby ...
... Capillary Blood Collection Tubes are 100% plastic ... wide range of applications, the Capillary Collection ... attached cap and a micro tube.,The capillary ... blood into the micro tube thereby eliminating ...
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
Medicine Products: